Status:
COMPLETED
Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Oxidative stress plays a key role in the pathogenesis of diabetes complications. Chronic hyperglycemia and disturbed lipid regulation commonly seen in diabetes are the main causes of this process. Des...
Eligibility Criteria
Inclusion
- Newly diagnosed type 2 diabetes patients based on American Diabetes Association criteria for diagnosis of diabetes
Exclusion
- No history of serious chronic illnesses of heart, lung, and kidney
- No prior treatment with anti-diabetes medications for either diabetes or conditions associated with hyperglycemia
- No intake of prescribed or over-the-counter vitamins C and E in the past year; - No intake of aspirin in the past year
- No history of excessive alcohol intake in the past year
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01521624
Start Date
October 1 2010
End Date
September 1 2011
Last Update
January 31 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tehran University of Medical Sciences
Tehran, Tehran Province, Iran, 13145-784